We therefore conclude that allosteric modulation and synergistic activation of a cell-type-specific GPR120 by ALA and EDA not only suppresses the disease progression but also counteracts the negative effects of AD pathology. This evidence concerns the gene FFAR4 and Alzheimer disease.